958 related articles for article (PubMed ID: 16846592)
1. S100A8 and S100A9 in inflammation and cancer.
Gebhardt C; Németh J; Angel P; Hess J
Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
[TBL] [Abstract][Full Text] [Related]
2. [Possibility of formation of the S100A8/A9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles].
Ishihara K; Namura T; Murayama H; Arai S; Totani M; Ikemoto M
Rinsho Byori; 2009 Apr; 57(4):324-31. PubMed ID: 19489433
[TBL] [Abstract][Full Text] [Related]
3. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
McNeill E; Hogg N
Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
[TBL] [Abstract][Full Text] [Related]
4. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
[TBL] [Abstract][Full Text] [Related]
5. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.
Gebhardt C; Breitenbach U; Tuckermann JP; Dittrich BT; Richter KH; Angel P
Oncogene; 2002 Jun; 21(27):4266-76. PubMed ID: 12082614
[TBL] [Abstract][Full Text] [Related]
6. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.
Ryckman C; McColl SR; Vandal K; de Médicis R; Lussier A; Poubelle PE; Tessier PA
Arthritis Rheum; 2003 Aug; 48(8):2310-20. PubMed ID: 12905486
[TBL] [Abstract][Full Text] [Related]
7. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity.
Nacken W; Roth J; Sorg C; Kerkhoff C
Microsc Res Tech; 2003 Apr; 60(6):569-80. PubMed ID: 12645005
[TBL] [Abstract][Full Text] [Related]
8. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
[TBL] [Abstract][Full Text] [Related]
9. The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant.
Nacken W; Kerkhoff C
FEBS Lett; 2007 Oct; 581(26):5127-30. PubMed ID: 17936757
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-associated S100 proteins: new mechanisms that regulate function.
Goyette J; Geczy CL
Amino Acids; 2011 Oct; 41(4):821-42. PubMed ID: 20213444
[TBL] [Abstract][Full Text] [Related]
11. [Possible mechanism for regulation of inflammatory responses with the S100A8/A9 protein].
Namura T; Arai S; Koike A; Yamada S; Totani M; Ikemoto M
Rinsho Byori; 2010 Jul; 58(7):651-7. PubMed ID: 20715507
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats.
Ikemoto M; Murayama H; Itoh H; Totani M; Fujita M
Clin Chim Acta; 2007 Feb; 376(1-2):197-204. PubMed ID: 17011539
[TBL] [Abstract][Full Text] [Related]
13. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
14. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
[TBL] [Abstract][Full Text] [Related]
15. Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils.
Ryckman C; Gilbert C; de Médicis R; Lussier A; Vandal K; Tessier PA
J Leukoc Biol; 2004 Aug; 76(2):433-40. PubMed ID: 15107458
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina.
Miyamoto S; Ueda M; Ikemoto M; Naruko T; Itoh A; Tamaki S; Nohara R; Terasaki F; Sasayama S; Fujita M
Heart; 2008 Aug; 94(8):1002-7. PubMed ID: 18308864
[TBL] [Abstract][Full Text] [Related]
17. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
18. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.
Ghavami S; Chitayat S; Hashemi M; Eshraghi M; Chazin WJ; Halayko AJ; Kerkhoff C
Eur J Pharmacol; 2009 Dec; 625(1-3):73-83. PubMed ID: 19835859
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum proteins that bind with S100A8, S100A9 and S100A8/A9: clinical significance of using proteins for monitoring the postoperative condition of liver recipients.
Namura T; Arai S; Okawa K; Koike A; Yamada S; Saita N; Nagae A; Itoh H; Totani M; Uemoto S; Ikemoto M
Clin Chim Acta; 2010 Nov; 411(21-22):1766-73. PubMed ID: 20674560
[TBL] [Abstract][Full Text] [Related]
20. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]